DJIA 17,719.00 33.27 0.19%
NASDAQ 4,701.87 26.16 0.56%
S&P 500 2,052.75 4.03 0.20%
market minute promo

VIVUS, Inc. (NASDAQ: VVUS)

3.17 0.13 (4.28%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VVUS $3.17 4.28%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.05
Previous Close $3.04
Daily Range $3.04 - $3.22
52-Week Range $2.97 - $10.29
Market Cap $328.7M
P/E Ratio -4.28
Dividend (Yield) $0.00 (0.0%)
Volume 1,639,518
Average Daily Volume 1,675,459
Current FY EPS -$0.78

Sector

Healthcare

Industry

Drugs

VIVUS, Inc. (VVUS) Description

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products. Website: http://www.vivus.com/

News & Commentary Rss Feed

For This Obesity Drug, Europe Trumps the U.S.

Europe is key for Orexigen's Contrave. Shares jumped despite problems with the U.S. launch.

Why VIVUS (VVUS) Might Be a Diamond in the Rough - Tale of the Tape

Janssen Is Working Its Way Toward Anti-Obesity

EnteroMedics May Enter The Obesity Space - What Does It Mean?

The 52-Week Low Club for Monday

What's Driving Orexigen Therapeutics Higher?

Orexigen Turns Around with Q3 Earnings Beat, Shares Soar - Analyst Blog

Bel-Phen Pilot Study News, Hold On To Your Shares

Can Arena Pharmaceuticals Inc. Overcome Belviq's Slow Launch?

Arena Pharmaceuticals stock has fallen hard after a slower than expected launch of its fat-fighting pill Belviq. During its third-quarter conference call, though, management gave three reasons investors should be optimistic moving forward.

Why Orexigen Therapeutics, Inc. Stock Skyrocketed

Orexigen Therapeutics is today's best biotech stock after reporting its third-quarter earnings results and providing an update on its Contrave program. Find out if its shares can motor even higher.

See More VVUS News...

VVUS's Top Competitors

VVUS $3.17 (4.28%)
Current stock: VVUS
JNJ $108.18 (-0.53%)
Current stock: JNJ
NVS $95.27 (-0.48%)
Current stock: NVS
RHHBY $37.68 (0.05%)
Current stock: RHHBY